Evidence map›Paper›PMID 36426717›Full record

ArticleLiver international : official journal of the International Association for the Study of the Liver2023

Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.

Ariel Jaffe, Tamar H Taddei, Edoardo G Giannini, Ysabel C Ilagan-Ying, Massimo Colombo, Mario Strazzabosco

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Liver international : official journal of the International Association for the Study of the Liver, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Ariel JaffeLiver Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Tamar H TaddeiLiver Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Edoardo G GianniniGastroenterology Unit, Department of Internal Medicine, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ysabel C Ilagan-YingLiver Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
Massimo ColomboLiver Center, San Raffaele Hospital, Milan, Italy.
Mario StrazzaboscoLiver Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.ORCID 0000-0002-1995-6331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsArtificial IntelligenceBiomarkers, TumorHumansPrognosisBiomarkers, Tumor

Identifiers

PMID36426717

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.